Overview: Tsutsugamushi Antibody TestIntroduction: The Tsutsugamushi Antibody Test detects scrub typhus antibodies to diagnose infection, causing fever or rash. Aligned with 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected scrub typhus.
Other Names: Scrub Typhus Antibody Assay, Orientia Tsutsugamushi Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Scrub typhus antibody testing began in the 1940s with tropical disease research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects Tsutsugamushi antibodies to diagnose scrub typhus, guides treatment, and evaluates patients with fever or rash.
Test Parameters: 1. Tsutsugamushi Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of fever, rash, or scrub typhus exposure.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fever, rash, or history of scrub typhus exposure, especially in endemic areas. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, scrub typhus implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) or immunofluorescence to detect Tsutsugamushi antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for tropical infection diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Cross-reactivity with other rickettsial infections may reduce specificity.
Clinical Significance: Positive antibodies confirm scrub typhus, guiding antibiotic therapy like doxycycline. Negative results may require PCR or repeat testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Scrub typhus PCR, Weil-Felix test, or clinical evaluation to confirm diagnosis.
Test Limitations: Non-specific for acute versus past infection; clinical correlation is needed. Sample quality affects sensitivity.
References: CDC Infectious Disease Guidelines, 2023; Clinical Infectious Diseases, Kelly DJ, 2022.
